GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,300 MG PER 130 ML (10 MG/ML) Trademark

Trademark Overview


On Thursday, September 20, 2018, a trademark application was filed for GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,300 MG PER 130 ML (10 MG/ML) with the United States Patent and Trademark Office. The USPTO has given the GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,300 MG PER 130 ML (10 MG/ML) trademark a serial number of 88125458. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by Sun Pharmaceutical Industries Limited. The GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,300 MG PER 130 ML (10 MG/ML) trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine

medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine
gemcitabine in 0.9% sodium chloride injection 1,300 mg per 130 ml (10 mg/ml)

General Information


Serial Number88125458
Word MarkGEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,300 MG PER 130 ML (10 MG/ML)
Filing DateThursday, September 20, 2018
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6200985
Registration DateTuesday, November 17, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements


Indication of Colors claimedThe color(s) blue, white and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,300 MG PER 130 ML (10 MG/ML)"
Description of Mark The mark consists of a blue outline of a rectangle surrounding the word "GEMCITABINE" in black lettering above the words "in 0.9% sodium chloride injection" in black lettering, along with a blue arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle filled in blue, with the words "1,300 mg per 130 mL (10 mg/mL)" in white letters. The color white in the rectangle with the arched curve represents background only and is not claimed as a feature of the mark.
Goods and Servicesmedicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
Goods and Servicesmedical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 26, 2018
Primary Code005
First Use Anywhere DateWednesday, July 8, 2020
First Use In Commerce DateWednesday, July 8, 2020

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, September 26, 2018
Primary Code010
First Use Anywhere DateWednesday, July 8, 2020
First Use In Commerce DateWednesday, July 8, 2020

Trademark Owner History


Party NameSun Pharmaceutical Industries Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMumbai, Maharashtra 400063
IN

Party NameSun Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMumbai, Maharashtra 400063
IN

Party NameSun Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMumbai, Maharashtra 400063
IN

Trademark Events


Event DateEvent Description
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Friday, October 16, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 15, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 13, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 29, 2020USE AMENDMENT FILED
Tuesday, October 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 29, 2020TEAS STATEMENT OF USE RECEIVED
Friday, April 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 22, 2020EXTENSION 2 GRANTED
Wednesday, April 22, 2020EXTENSION 2 FILED
Wednesday, April 22, 2020TEAS EXTENSION RECEIVED
Friday, October 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2019EXTENSION 1 GRANTED
Wednesday, October 23, 2019EXTENSION 1 FILED
Wednesday, October 23, 2019TEAS EXTENSION RECEIVED
Tuesday, April 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 15, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, January 15, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 15, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, January 15, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, January 14, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, January 8, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, December 21, 2018ASSIGNED TO LIE
Thursday, November 29, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 29, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, November 29, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 29, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, November 29, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 27, 2018ASSIGNED TO EXAMINER
Thursday, September 27, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, September 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 24, 2018NEW APPLICATION ENTERED IN TRAM